Asian markets, risk assets ride up on vaccine hopes By Reuters

© Reuters. An SGX sign is pictured at Singapore Stock Exchange

By Swati Pandey

SYDNEY (Reuters) – Asian shares jumped on Wednesday as optimism about a coronavirus vaccine bolstered risk appetite while the euro rose to a four-month top on the prospect of stimulus ahead of a crucial EU summit.

MSCI’s broadest index of Asia-Pacific shares outside Japan () rose 1.2%, edging closer to a recent five-month peak.

Japan’s Nikkei () added 1.5% to the highest since June 10 while Australia’s benchmark index was up 1%. Chinese shares gained modestly with the blue-chip CSI300 index () ticking up 0.3%.

E-mini futures for the S&P 500 rose 0.8%.

Risk appetite was boosted by Moderna Inc’s (O:) experimental vaccine for COVID-19 which showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study.

On Tuesday, the Dow Jones Industrial Average () rose over 2%, while the S&P 500 () gained 1.34% and the Nasdaq Composite () climbed 0.94%. ()

“… the vaccine is more than a show stopper. It’s the ultimate recession stopper,” said Stephen Innes, markets strategist at AxiCorp.

The stock surge came despite lingering bad news about the coronavirus and after three U.S. states reported new record daily deaths from the pandemic, while tensions continued to grow between the United States and China.

“Although a mismatch between financial markets and the real economy remains in full effect, the removal of a single recessionary input (the virus) via a vaccine can pave the way for fast economic recovery,” Innes added.

“So, the positive news on the vaccine can go a long way to explain the dissonance between the shift in the stock market sentiment relative to the angst on Main Street.”

Simmering tensions between the United States and China also loom large, after U.S. President Donald Trump signed legislation and an executive order to hold China “accountable” for the national security law it imposed on Hong Kong.

The dollar was on the defensive, particularly against risk-sensitive currencies, following news of progress in vaccine development.

The euro () rose to as high as $1.1423, its strongest since March 10 and not far off its peak so far this year of $1.1495.

The single currency has been helped by hopes the European Union could agree at its summit later this week on a rescue financing package that will limit the economic damage to the bloc from the coronavirus pandemic.

The euro’s strength helped to push the () to 96.056, a one-month low.

The yen was little moved at 107.27 per dollar , off a two-week high of 106.635 ahead of the Bank of Japan’s policy announcement later in the day where it is expected to keep monetary policy steady.

The risk-sensitive Australian dollar rose 0.5% to $0.7009 .

There were still signs of wariness among investors, as yields on leading U.S. and euro zone government debt fell and safe-haven gold prices solidified gains above $1,800 an ounce.

rose to $1,809 an ounce.

Oil prices rose on Wednesday after a sharp drop in U.S. crude inventories. Brent crude () futures were up 10 cents at $43 a barrel, and U.S. crude () futures rose 14 cents to $40.43 a barrel. [O/R]

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*